-
- T J Rintala
- Institute of Biomedicine, University of Eastern Finland , 70210 Kuopio , Finland
-
- Arindam Ghosh
- Institute of Biomedicine, University of Eastern Finland , 70210 Kuopio , Finland
-
- V Fortino
- Institute of Biomedicine, University of Eastern Finland , 70210 Kuopio , Finland
説明
<jats:title>Abstract</jats:title><jats:p>The network approach is quickly becoming a fundamental building block of computational methods aiming at elucidating the mechanism of action (MoA) and therapeutic effect of drugs. By modeling the effect of drugs and diseases on different biological networks, it is possible to better explain the interplay between disease perturbations and drug targets as well as how drug compounds induce favorable biological responses and/or adverse effects. Omics technologies have been extensively used to generate the data needed to study the mechanisms of action of drugs and diseases. These data are often exploited to define condition-specific networks and to study whether drugs can reverse disease perturbations. In this review, we describe network data mining algorithms that are commonly used to study drug’s MoA and to improve our understanding of the basis of chronic diseases. These methods can support fundamental stages of the drug development process, including the identification of putative drug targets, the in silico screening of drug compounds and drug combinations for the treatment of diseases. We also discuss recent studies using biological and omics-driven networks to search for possible repurposed FDA-approved drug treatments for SARS-CoV-2 infections (COVID-19).</jats:p>
収録刊行物
-
- Briefings in Bioinformatics
-
Briefings in Bioinformatics 23 (4), 2022-06-16
Oxford University Press (OUP)